Our global portfolio has approximately 1,400 molecules across a broad range of therapeutic areas spanning non-communicable and infectious diseases, including brand-name products, generics and OTC medicines.

Our diverse portfolio delivers trusted, quality medicines that treat 9 out of 10 of the World Health Organisation’s (WHO) leading causes of death and more than 200 of our medicines are on the WHO Essential Medicines List.

• We are a leading supplier of medicines to the HIV/AIDS community, providing access to high quality and affordable antiretrovirals in over 100 countries. Globally, approximately 40% of the 23.31 million people on treatment for HIV use our products.
• In New Zealand, we are one of the largest healthcare companies, supplying 1 in 5 doses of medication across the country. We are also the leading supplier by volume, with over one million units delivered directly through our warehouse every month.
• We are driven by the desire to make a real difference in patients’ lives. We aim to bring new medicines to market and make them affordable for all New Zealanders. The scale and flexibility of our global supply chain combined with our extensive distribution network ensures our medicines can be readily available.
• We take a leading role in our collaboration with healthcare professionals. We work with many healthcare professional groups in New Zealand, from nurses and general practitioners in primary care, dispensing and retail staff in community pharmacy, right through to specialists within hospitals and private clinics.